Nieun Seo MD, Presenter: Nothing to Disclose

So Yeon Kim MD, Abstract Co-Author: Nothing to Disclose

Jin Hee Kim MD, Abstract Co-Author: Nothing to Disclose

Seung Soo Lee MD, Abstract Co-Author: Nothing to Disclose

Seong Ho Park MD, Abstract Co-Author: Research Grant, DONGKOOK Pharmaceutical Co, Ltd Research Grant, General Electric Company

Hyoung Jung Kim MD, Abstract Co-Author: Nothing to Disclose

Jae Ho Byun MD, Abstract Co-Author: Nothing to Disclose

Moon-Gyu Lee MD, Abstract Co-Author: Nothing to Disclose

1. To outline the current concept in sclerosing cholangitis 2. To present an imaging atlas of sclerosing cholangitis with relevant clinical features and pathogenesis 3. To discuss the risks and imaging characteristics of cholangiocarcinoma in patients with sclerosing cholangitis 4. To establish a systematic approach to the differential diagnosis of sclerosing cholangitis

1. Introduction of the current concept in sclerosing cholangitis 2. Disease spectrum, clinical significance, and imaging findings (1) Primary sclerosing cholangitis i. Definition ii. Clinical significance iii. Imaging features (2) Secondary sclerosing cholangitis i. Etiology: IgG4-related sclerosing cholangitis,recurrent pyogenic cholangitis, ischemic cholangiopathy, AIDS cholangiopathy, Eosinophilic cholangitis, Portal biliopathy ii. Clinical significance iii. Imaging features characteristic to different etiologies (3) Risk of cholangiocarcinoma: Associated etiology and image features 3. Systematic approach to differential diagnosis of sclerosing cholangitis

http://abstract.rsna.org/uploads/2014/14002905/14002905_y8ol.pdf

Seo, N, Kim, S, Kim, J, Lee, S, Park, S, Kim, H, Byun, J, Lee, M, Sclerosing Cholangitis: Guide to Navigate through Winding and Bumpy Bile Ducts.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14002905.html